IDiyas

For the Inventor, By the Inventor

Basel, Switzerland

Thierry Godel

USPTO Granted Patents = 24



Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 290(Granted Patents)


Location History:

  • Reinach, CH (1994)
  • Basle, CH (2001 - 2002)
  • Basel, CH (1995 - 2004)

Company Filing History:

goldMedal24 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1994-2004

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents
1. 6770637 - Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors (2004-08-03),
2. 6756380 - 5-phenyl-pyrimidine derivatives (2004-06-29),
3. 6596773 - Phenyl substituted pyridine and benzene derivatives (2003-07-22),
4. 6552088 - Biphenyl derivatives (2003-04-22),
5. 6482829 - Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor (2002-11-19),
6. 6479483 - 4-phenyl-pyridine derivatives (2002-11-12),
7. 6452001 - Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation (2002-09-17),
8. 6407111 - Phenyl substituted pyridine and benzene derivatives (2002-06-18),
9. 6297375 - 4-phenyl-pyridine derivatives (2001-10-02),
10. 6291465 - Biphenyl derivatives (2001-09-18),
11. 6274588 - 4-phenyl-pyrimidine derivatives (2001-08-14),
12. 6225316 - 3-phenyl-pyridine-derivatives (2001-05-01),
13. 6030976 - Use of sulfonamides (2000-02-29),
14. 5962450 - Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use (1999-10-05),
15. 5932599 - Use of sulfonamides (1999-08-03),

Title: Thierry Godel: Innovator in Pharmaceutical Chemistry

Introduction

Thierry Godel is a prominent inventor based in Basel, Switzerland, recognized for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 24 patents, Godel has established himself as a key figure in the development of innovative therapeutic compounds.

Latest Patents

Among his most recent inventions are two notable patents that focus on substituted 4-phenyl-pyridine compounds. These compounds exhibit activity as antagonists of neurokinin-1 receptors, which are important targets in various therapeutic areas. Additionally, Godel's patents detail the methods for making these compounds and preparing 5-phenyl-pyrimidine derivatives, showcasing his expertise in synthetic chemistry and drug development.

Career Highlights

Thierry Godel currently works at Hoffmann-La Roche Inc., a leading global healthcare company known for its research and development of innovative medical solutions. His work at Hoffmann-La Roche has contributed significantly to advancements in pharmaceuticals, particularly in the areas relating to neurokinin receptor antagonism.

Collaborations

Throughout his career, Godel has collaborated with talented colleagues, including Guido Galley and Torsten Hoffmann. These partnerships have played a crucial role in fostering a creative and productive research environment, leading to groundbreaking discoveries in the field.

Conclusion

In conclusion, Thierry Godel's work exemplifies the intersection of innovation and practical application in the pharmaceutical industry. With his extensive patent portfolio and collaborations with notable professionals, Godel continues to drive advancements that hold promise for future therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…